Verve Therapeutics Inc (VERV)

33.31 -0.77  -2.26% NASDAQ Dec 1, 16:00 32.05 -1.26  -3.78% After-Hours: 20:00 USD

Verve Therapeutics Cash from Operations (TTM):

-64.81M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -64.81M
June 30, 2021 -49.78M
March 31, 2021 -43.58M
Dec. 31, 2020 -35.26M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

Regenxbio Inc -67.89M
Krystal Biotech Inc -35.06M
Beam Therapeutics Inc -92.40M

Cash from Operations (TTM) Range, Past 5 Years

Minimum -64.81M Sep 2021
Maximum -35.26M Dec 2020
Average -48.36M


Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.